Measuring Neurological Disorders of Movement
Why is new technology needed to measure cerebellar ataxia
Cerebellar ataxia often results in imbalance and falls, reduced arm and hand dexterity, impaired vision, loss of speech clarity and communication challenges, disturbed swallow and the risk of choking and pneumonia.
Cerebellar ataxia can be caused by genetic diseases, stroke, tumours or multiple sclerosis.
Being able to accurately measure ataxia will help develop our understanding of these conditions and assist clinicians to monitor the effect of therapies and is very important in the development of new treatments.
Research into an accurate measurement of and improved therapies for cerebellar ataxias
Associate Professor David Szmulewicz is leading research into new technologies that utilise wearable sensors and artificial intelligence to produce more accurate measurements of ataxia and the use of these technologies to improve therapies for a cerebellar ataxias.
The development of objective and sensitive measurement of ataxia patient symptoms is very important for ongoing management of patients as well as guiding the development of potential new therapeutic approaches.
A/Prof Szmulewicz’s team utilises his world renowned clinical knowledge and experience, links to international pharmaceutical industry and biomedical engineering expertise.
Next steps for Bionics Institute researchers
Associate Professor David Szmulewicz and his team are in the process of setting up clinical trial in remote communities to provide people with limited access to specialist care with an accurate measure of their disease progression, and treatment effectiveness.
Once efficacy of the device has been established it could be used to test potential gene therapy treatments for ataxia.
The devices are also finding usefulness in other diseases that affect movement.
The research team
Bionics Institute lead researchers:
Associate Professor David Szmulewicz and Jemimah Harding.
External researchers:
Professor Pubudu Pathirana (Deakin University), Associate Professor Louise Corben (Murdoch Institute), Associate Professor Ian Harding (QMIR Beghofer Medical Research Institute), Dr Hamish MacDougall (Honorary Bionics Institute position)
Key publications
- T. Ngo, P. N. Pathirana, M. K. Horne, L. A. Corben, I. H. Harding and D. J. Szmulewicz Technological Evolution in the Instrumentation of Ataxia Severity Measurement. IEEE Access 2023; 11:14006-14027. DOI: https://doi.org/10.1109/ACCESS.2023.3243178
- Kashyap B, Pathirana PN, Horne M, Power L, Szmulewicz DJ. Machine Learning Based Scoring System to Predict the Risk and Severity of Ataxic Speech Using Different Speech Tasks. IEEE Trans Neural Syst Rehabil Eng. 2023. Epub ahead of print. DOI: 10.1109/TNSRE.2023.3334718
- Krishna R, Pathirana PN, Horne M, Corben L, Szmulewicz DJ. Quantitative assessment of Friedreich Ataxia via self-drinking. IEEE Journal of Biomedical and Health Informatics 2021;25:1985-1996 DOI: 10.1109/JBHI.2021.3069007
- Tran H, Nguyen, KD, Pathirana PN, Horne MK, Power L, Szmulewicz DJ. A comprehensive scheme for the objective upper body assessments of subjects with cerebellar ataxia. J NeuroEngineering Rehabil 2020; 17(1):162 DOI: https://doi.org/10.1186/s12984-020-00790-3
- Kashyap B, Phan D, Pathirana PN, Horne M, Power L, Szmulewicz D. Objective Assessment of Cerebellar Ataxia: A Comprehensive and Refined Approach. Sci Rep. 2020;10(1):9493 DOI: https://doi.org/10.1038/s41598-020-65303-7